TMCnet News
Upgrade Alert for Allergan (AGN)May 02, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Allergan (AMEX:AGN) was upgraded from Neutral to Buy at Lazard Capital today. The stock closed yesterday at $100.71 on volume of 18.2 million shares, above average daily volume of 1.2 million. Allergan has overhead space with shares priced $100.71, or 12.7% below the average consensus analyst price target of $115.35. Allergan shares should encounter resistance at the 50-day moving average (MA) of $111.10 and support at its 200-day MA of $97.47. Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world. In the past 52 weeks, shares of Allergan have traded between a low of $81.28 and a high of $116.45 and closed yesterday at $100.71, which is 24% above that low price. The 200-day and 50-day moving averages have moved 0.29% higher and 0.06% higher over the past week, respectively. SmarTrend is monitoring the recent change of momentum in Allergan. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Allergan in search of a potential trend change. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup |